Bristol-Myers Squibb (BMY) Reports Q3 Revenue of $11.22B, EP

Bristol-Myers Squibb (BMY) Reports Q3 Revenue of $11.22B, EPS of $1.99

Bristol-Myers Squibb (BMY) Reports Q3 Revenue of $11.22B, EPS of $1.99
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Japan , United States , Russia , Ukraine , Russian Federation , Pomalyst Imnovid , Bristol Myers Squibb , Giovanni Caforio , Instagram , York Heart Association , Linkedin , Twitter , Health Equity Commitments , Nasdaq , Japan Ministry Of Health , European Union , Clinical Research , Facebook , B Drug Pricing Program , Drug Administration , European Commission , Exchange Commission , Point Therapeutics Inc , Youtube , Securities Exchange , Business Development , Myers Squibb , Bristol Myers , Per Share , Turning Point Therapeutics , Turning Point , In Line Products , New Product Portfolio , New York Heart Association , Prescription Drug User Fee Act , Bristol Myers Squibb Janssen , Blinded Independent Central , Diversity Report , Global Inclusion , Accepted Accounting Principles , Securities Act , Securities Exchange Act , Drug Pricing Program , Russian Federation Ukraine , Annual Report , Quarterly Reports , Current Reports ,